Medindia1d
Tirzepatide: Combating Obesity, Kidney Disease, and Heart Failure Together
Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...
Pharmaceutical Technology1d
ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
Healio3d
Tirzepatide improves outcomes in HFpEF, obesity regardless of kidney function
In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...
Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...
Medical Dialogues9h
Trial Shows Tirzepatide May Benefit People with Obesity, Kidney Disease and Heart Failure
In the new analysis of data from the SUMMIT trial, researchers focused on patients with obesity, chronic kidney disease and heart failure with preserved ejection fraction because they commonly have ...
News Medical3d
Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF
Packer, M., et al. (2025) Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial. JACC . doi ...
Managed Healthcare Executive3d
Positive Results for Tirzepatide in Those With the Cardiovascular-Kidney-Metabolic Triad | ACC 2025
Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...
Physician's Weekly2d
Epicardial Fat and Heart Failure with Preserved Ejection Fraction
The following is a summary of "Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure ...
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit
The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...